Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RLX030 in Asian patients with acute heart failure
CTR20150806Phase 3Suspended
- Sponsor
- Novartis
- Start
- Jan 2016
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of serelaxin in Acute Heart Failure (AHF), sponsored by Novartis. Started Jan 2016; status: suspended.
02
Drugs
serelaxin
03
Conditions
Acute Heart Failure (AHF)
Beyond the preview
Go deeper on CTR20150806.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150806.